Facial hyperpigmentation happens when patches of skin produce excess melanin, the pigment that gives skin its color. The causes range from sun exposure and hormonal shifts to inflammation, medications, and underlying health conditions. In most cases, more than one trigger is at work, and understanding which ones apply to you is the first step toward addressing it.
How Excess Melanin Forms
Melanin is made inside specialized skin cells called melanocytes, through a chain of chemical reactions. The process starts when an amino acid, tyrosine, gets converted into a series of intermediate compounds that eventually build into melanin pigment. The key enzyme driving this process is tyrosinase, which acts as the rate-limiting step. If tyrosinase activity increases, melanin production ramps up.
Several signals can push tyrosinase into overdrive. UV radiation, inflammation, and hormones all activate a master regulator protein called MITF, which in turn boosts tyrosinase and other enzymes involved in pigment production. This is why so many different triggers, from a sunburn to a pimple to a pregnancy, can all end at the same destination: darker patches on your face. The face is particularly vulnerable because it gets more cumulative sun exposure than almost any other part of the body, and facial skin has a higher density of melanocytes than most other areas.
Sun Exposure and Visible Light
Ultraviolet radiation is the single most common driver of facial hyperpigmentation. UV rays directly stimulate melanocytes to produce more pigment, and they also cause DNA damage that triggers protective pigmentation. Even brief, repeated sun exposure accumulates over years, producing uneven dark spots often called sunspots or solar lentigines. These tend to appear on the forehead, cheeks, nose, and upper lip, the areas that catch the most light.
What surprises many people is that UV isn’t the only part of the light spectrum that matters. High-energy visible light, sometimes called blue light, also stimulates melanin production through a receptor pathway in the skin called opsin-3. This means that intense, prolonged exposure to sunlight (even through windows that block UV) can contribute to pigmentation changes, particularly in darker skin tones. Blue light from screens is a much weaker source by comparison, but the outdoor visible light spectrum is significant enough that broad-spectrum sun protection alone may not cover all the relevant wavelengths.
Hormonal Changes and Melasma
Melasma is the classic hormonal form of facial hyperpigmentation, producing symmetrical brown or grayish patches typically on the cheeks, forehead, upper lip, and bridge of the nose. It is strongly associated with estrogen and progesterone, which is why it’s common in pregnant women, women taking oral contraceptives, and women using hormone replacement therapy during menopause. Between 15% and 50% of pregnant women develop melasma at some point during pregnancy.
Globally, melasma affects roughly 1% to 10% of the general population, but rates climb sharply in certain groups. Among Latino women in the United States, prevalence runs around 8% to 9%. In Brazilian women, rates reach 15% to 35%. Studies in Iran report nearly 40% of women affected, and among outdoor agricultural workers in India and Pakistan, prevalence can reach 41% to 46%, reflecting the compounding effect of hormones and intense sun exposure together.
The good news is that melasma often fades on its own over several months once the hormonal trigger is removed, whether that means delivering a baby or stopping oral contraceptives. The bad news is that it frequently returns with future pregnancies or if hormonal medications are restarted, and sun exposure can make existing melasma significantly worse or keep it from resolving.
Post-Inflammatory Hyperpigmentation
Any time your facial skin is inflamed or injured, the healing process can leave behind dark marks. This is called post-inflammatory hyperpigmentation, or PIH, and it’s one of the most common causes of uneven skin tone on the face. Acne is the leading culprit, but eczema, psoriasis, allergic reactions, burns, and even aggressive cosmetic procedures can all trigger it.
What’s notable about acne-related PIH is that it doesn’t require severe breakouts. Research shows that dark marks can develop even from mild to moderate acne, sometimes without visible signs of significant inflammation. The process involves the immune system, the skin’s resident bacteria, and external factors like UV radiation and air pollution, all of which can amplify pigment deposition during the healing phase.
Skin tone plays a major role in how pronounced PIH becomes and how long it lasts. Darker skin is substantially more prone to developing post-inflammatory brown marks after any injury. In lighter skin, PIH tends to fade within a few weeks to months. In deeper skin tones, it can persist for a year or longer, sometimes outlasting the original condition that caused it.
Medications That Darken Skin
A surprisingly long list of medications can cause facial hyperpigmentation, often in sun-exposed areas. The patterns vary by drug class:
- Antimalarials can produce yellow-brown to bluish-black discoloration on the face, shins, nails, and inside the mouth.
- Certain antibiotics, particularly minocycline (a tetracycline), cause grayish discoloration of acne scars, the face, and other areas.
- Chemotherapy drugs including cyclophosphamide and 5-fluorouracil can trigger diffuse darkening across the skin.
- Heart medications like amiodarone produce a distinctive slate-gray to violet discoloration on sun-exposed skin.
- Some antidepressants in the tricyclic class cause grayish-blue discoloration, again concentrated where the face gets sun.
- Oral contraceptives contribute both through hormonal melasma and direct pigmentary effects.
Ironically, hydroquinone, a common skin-lightening ingredient, can itself cause a bluish-black darkening of the face and ears after years of continuous use. This rebound effect is one reason hydroquinone is typically recommended in limited cycles rather than as a permanent treatment.
Underlying Medical Conditions
Diffuse or unusual facial darkening can sometimes signal an underlying health problem. Addison’s disease, a condition where the adrenal glands don’t produce enough hormones, is one of the most well-known examples. When the adrenal glands fail, the body produces excess ACTH, a hormone that happens to bind to the same receptors that stimulate melanin production. The result is widespread hyperpigmentation that often shows up prominently on the face, in skin creases, and on the gums and lips.
Other systemic conditions linked to facial darkening include hyperthyroidism, poorly controlled diabetes, and hemochromatosis (a condition where the body stores too much iron). These are relatively uncommon causes, but they’re worth knowing about because the hyperpigmentation they produce tends to be more generalized and symmetrical than sun damage or acne marks, and it won’t respond to topical treatments until the underlying condition is addressed.
Vitamin B12 Deficiency
Low vitamin B12 levels can cause a distinctive hyperpigmentation, particularly on the face and hands. Research published in JAMA Dermatology found that skin cells in pigmented areas of B12-deficient patients had abnormally enlarged nuclei, a cellular change linked directly to the deficiency state rather than to some secondary process. When patients received B12 supplementation, those cellular abnormalities returned to normal, supporting a direct causal link between the vitamin deficiency and the pigment changes.
B12 deficiency is more common than many people realize, especially in vegetarians, vegans, older adults, and people with digestive conditions that impair nutrient absorption. If facial darkening appears alongside fatigue, tingling in the hands or feet, or difficulty concentrating, B12 status is worth investigating with a simple blood test.
Why Multiple Factors Usually Overlap
In practice, facial hyperpigmentation rarely has a single clean cause. A woman on oral contraceptives who also gets occasional acne and lives in a sunny climate is dealing with hormonal, inflammatory, and UV-driven pigmentation simultaneously. Someone taking minocycline for acne might develop both PIH from the breakouts and drug-induced discoloration from the medication itself. This layering effect is why facial hyperpigmentation can be stubbornly persistent and why the most effective approach usually involves identifying and addressing as many contributing triggers as possible rather than focusing on just one.